A Commitment Device for Medication Adherence Among HIV Patients
Acquired Immunodeficiency Syndrome, HIV
About this trial
This is an interventional health services research trial for Acquired Immunodeficiency Syndrome focused on measuring Acquired Immunodeficiency Syndrome, HIV, Commitment, Financial Incentives
Eligibility Criteria
Inclusion Criteria:
- Attended the Grady Health System Infectious Disease Program (IDP)
- Most recent HIV-1 plasma RNA viral load (pVL) > 200 copies/mL; this value must have been measured within the prior 18 months and at least 6 months after starting the current ART regimen
- English-speaking
Exclusion Criteria:
- Using pillboxes
- Were planning to relocate
- Were enrolled in another trial
Sites / Locations
- Emory University Ponce Clinic
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
Provider Visit Incentive (PVI)
Incentive Choice (IC)
Passive Control (PC)
Participants were told that they would receive $30 after attending each scheduled provider visit (a CCT). A block randomization scheme, stratified on whether or not the majority of the participant's three previous viral load measurements were suppressed, assigned 21 individuals to the PVI arm.
Participants were given a choice between the CCT described in the PVI arm and a commitment contract, which made the $30 payment conditional on the patient attending the provider visit AND meeting an ART adherence threshold. A block randomization scheme, stratified on whether or not the majority of the participant's three previous viral load measurements were suppressed, assigned 19 individuals to the IC arm.
The study also included 70 individuals in a PC arm, who did not receive financial incentives. Individuals in the PC arm were not enrolled in the randomized trial but met basic study eligibility criteria during the same time period.